The presence of a SSc autoantibody (ACENP, ATA, anti-Th/To, or anti-RNA polymerase III) and abnormal nailfold capillaries at baseline increased likelihood of developing definite SSc by 60-fold, whereas their absence at baseline practically ruled out this outcome (negative predictive value 98%). This evidence concerns the gene ATM and systemic sclerosis.